Integrase strand transfer inhibitors (INSTIs) are a newer class of antiretroviral drugs that block HIV replication. They block integrase, an HIV-coded enzyme, and thereby prevent the virus from incorporating its genetic information into the host cell DNA. These drugs have played a key role in HIV therapy.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China's reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the HIV Integrase Strand Transfer Inhibitors (INSTI) industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
- Raltegravir
- Elvitegravir Combination Drugs
- Dolutegravir and Its Combination Drug
- Bictegravir Combination Drug
- Cabotegravir
- Other
Market Segment by Product Application
- Hospital
- Clinic
- Drug Center
- Other
Finally, the report provides detailed profile and data information analysis of leading company.
- Adcock Ingram Limited
- Flamingo Pharmaceuticals Limited
- Biocon Limited
- Affine Formulations Limited
- Emcure Pharmaceuticals
- Aurobindo Pharma
- Hetero Drugs
- Cipla
- Bristol-Myers Squibb
- Gilead Sciences
- Merck
- Shanghai Desano Pharmaceuticals
- IPCA Laboratories
- Mylan
- Medisist Pharma
- Janssen Pharmaceutica (Johnson & Johnson)
- ViiV Healthcare (GSK)
- Ranbaxy Pharmaceuticals
- LAURUS Labs
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
- 1.To study and analyze the global HIV Integrase Strand Transfer Inhibitors (INSTI) consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
- 2.To understand the structure of HIV Integrase Strand Transfer Inhibitors (INSTI) market by identifying its various subsegments.
- 3.Focuses on the key global HIV Integrase Strand Transfer Inhibitors (INSTI) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- 4.To analyze the HIV Integrase Strand Transfer Inhibitors (INSTI) with respect to individual growth trends, future prospects, and their contribution to the total market.
- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- 6.To project the consumption of HIV Integrase Strand Transfer Inhibitors (INSTI) submarkets, with respect to key regions (along with their respective key countries).
- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- 8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Professional Survey Report 2023, Forecast to 2028
Table of Contents
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Professional Survey Report Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Type
2.1.1 Raltegravir
2.1.2 Elvitegravir Combination Drugs
2.1.3 Dolutegravir and Its Combination Drug
2.1.4 Bictegravir Combination Drug
2.1.5 Cabotegravir
2.1.6 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Drug Center
2.2.4 Other
2.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Comparison by Regions (2018-2028)
2.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2018-2028)
2.3.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2018-2028)
2.3.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2018-2028)
2.3.4 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2018-2028)
2.3.5 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2018-2028)
2.3.6 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Impact
2.5.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Business Impact Assessment - Covid-19
2.5.2 Market Trends and HIV Integrase Strand Transfer Inhibitors (INSTI) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Manufacturer (2018-2023)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer Market Share
3.5 Top 10 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
3.7 Key Manufacturers HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Key Manufacturers
4.1 Adcock Ingram Limited
4.1.1 Company Details
4.1.2 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Adcock Ingram Limited News
4.2 Flamingo Pharmaceuticals Limited
4.2.1 Company Details
4.2.2 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.2.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Flamingo Pharmaceuticals Limited News
4.3 Biocon Limited
4.3.1 Company Details
4.3.2 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.3.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Biocon Limited News
4.4 Affine Formulations Limited
4.4.1 Company Details
4.4.2 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.4.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Affine Formulations Limited News
4.5 Emcure Pharmaceuticals
4.5.1 Company Details
4.5.2 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.5.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Emcure Pharmaceuticals News
4.6 Aurobindo Pharma
4.6.1 Company Details
4.6.2 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.6.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Aurobindo Pharma News
4.7 Hetero Drugs
4.7.1 Company Details
4.7.2 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.7.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.5 Hetero Drugs News
4.8 Cipla
4.8.1 Company Details
4.8.2 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.8.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 Cipla News
4.9 Bristol-Myers Squibb
4.9.1 Company Details
4.9.2 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.9.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Bristol-Myers Squibb News
4.10 Gilead Sciences
4.10.1 Company Details
4.10.2 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.10.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 Gilead Sciences News
4.11 Merck
4.11.1 Company Details
4.11.2 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.11.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.11.4 Main Business Overview
4.11.5 Merck News
4.12 Shanghai Desano Pharmaceuticals
4.12.1 Company Details
4.12.2 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.12.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.12.4 Main Business Overview
4.12.5 Shanghai Desano Pharmaceuticals News
4.13 IPCA Laboratories
4.13.1 Company Details
4.13.2 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.13.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.13.4 Main Business Overview
4.13.5 IPCA Laboratories News
4.14 Mylan
4.14.1 Company Details
4.14.2 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.14.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.14.4 Main Business Overview
4.14.5 Mylan News
4.15 Medisist Pharma
4.15.1 Company Details
4.15.2 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.15.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.15.4 Main Business Overview
4.15.5 Medisist Pharma News
4.16 Janssen Pharmaceutica (Johnson & Johnson)
4.16.1 Company Details
4.16.2 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.16.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.16.4 Main Business Overview
4.16.5 Janssen Pharmaceutica (Johnson & Johnson) News
4.17 ViiV Healthcare (GSK)
4.17.1 Company Details
4.17.2 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.17.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.17.4 Main Business Overview
4.17.5 ViiV Healthcare (GSK) News
4.18 Ranbaxy Pharmaceuticals
4.18.1 Company Details
4.18.2 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.18.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.18.4 Main Business Overview
4.18.5 Ranbaxy Pharmaceuticals News
4.19 LAURUS Labs
4.19.1 Company Details
4.19.2 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.19.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.19.4 Main Business Overview
4.19.5 LAURUS Labs News
5 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Categorized by Regions
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Sales and Market Share by Regions
5.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Regions (2018-2023)
5.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Regions (2018-2023)
5.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
5.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
5.4 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
5.5 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
5.6 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
6 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
6.1.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2018-2023)
6.1.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2018-2023)
6.1.3 United States HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
6.1.4 Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
6.1.5 Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
6.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Value) by Manufacturers
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2018-2023)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2018-2023)
7 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
7.1.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2018-2023)
7.1.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2018-2023)
7.1.3 Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
7.1.4 UK HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
7.1.5 France HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
7.1.6 Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
7.1.7 Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
7.1.8 Spain HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Value) by Manufacturers
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2018-2023)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2018-2023)
8 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
8.1 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2018-2023)
8.1.2 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2018-2023)
8.1.3 China HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
8.1.4 South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
8.1.5 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
8.1.6 Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
8.1.7 India HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
8.1.8 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
8.2 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Value) by Manufacturers
8.3 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2018-2023)
8.4 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2018-2023)
9 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
9.1 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
9.1.1 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2018-2023)
9.1.2 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2018-2023)
9.1.3 Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
9.2 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2018-2023)
9.3 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2018-2023)
10 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
10.1 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2018-2023)
10.1.2 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2018-2023)
10.1.3 GCC Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
10.1.4 Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
10.1.5 Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
10.1.6 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2018-2023)
10.2 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type
10.3 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2018-2023)
11 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Type
11.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Sales and Market Share by Type (2018-2023)
11.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2018-2023)
11.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Type (2018-2023)
11.2 Raltegravir Sales Growth Rate and Price
11.2.1 Global Raltegravir Sales Growth Rate (2018-2023)
11.2.2 Global Raltegravir Price (2018-2023)
11.3 Elvitegravir Combination Drugs Sales Growth Rate and Price
11.3.1 Global Elvitegravir Combination Drugs Sales Growth Rate (2018-2023)
11.3.2 Global Elvitegravir Combination Drugs Price (2018-2023)
11.4 Dolutegravir and Its Combination Drug Sales Growth Rate and Price
11.4.1 Global Dolutegravir and Its Combination Drug Sales Growth Rate (2018-2023)
11.4.2 Global Dolutegravir and Its Combination Drug Price (2018-2023)
11.5.1 Global Bictegravir Combination Drug Sales Growth Rate (2018-2023)
11.5.2 Global Bictegravir Combination Drug Price (2018-2023)
11.6 Cabotegravir Sales Growth Rate and Price
11.6.1 Global Cabotegravir Sales Growth Rate (2018-2023)
11.6.2 Global Cabotegravir Price (2018-2023)
11.7 Other Sales Growth Rate and Price
11.7.1 Global Other Sales Growth Rate (2018-2023)
11.7.2 Global Other Price (2018-2023)
12 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Application
12.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2018-2023)
12.2 Hospital Sales Growth Rate (2018-2023)
12.3 Clinic Sales Growth Rate (2018-2023)
12.4 Drug Center Sales Growth Rate (2018-2023)
12.5 Other Sales Growth Rate (2018-2023)
13 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast
13.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Sales and Growth Rate (2023-2028)
13.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Regions (2023-2028)
13.2.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2023-2028)
13.2.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2023-2028)
13.2.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2023-2028)
13.2.4 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2023-2028)
13.2.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2023-2028)
13.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Type (2023-2028)
13.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Type (2023-2028)
13.3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Type (2023-2028)
13.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Application (2023-2028)
13.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Application (2023-2028)
13.4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Application (2023-2028)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture HIV Integrase Strand Transfer Inhibitors (INSTI)
Figure Market Concentration Ratio and Market Maturity Analysis of HIV Integrase Strand Transfer Inhibitors (INSTI)
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
Figure Global Market Share of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type in 2022
Figure Raltegravir Picture
Figure Elvitegravir Combination Drugs Picture
Figure Dolutegravir and Its Combination Drug Picture
Figure Bictegravir Combination Drug Picture
Figure Cabotegravir Picture
Figure Other Picture
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (Volume) by Application
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Comparison by Regions (M USD) 2018-2028
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (Million US$) (2018-2028)
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2018-2028)
Figure Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2018-2028)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2018-2028)
Figure Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and HIV Integrase Strand Transfer Inhibitors (INSTI) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Manufacturer (2018-2023)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Manufacturer in 2022
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Manufacturer (2018-2023)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Manufacturer in 2022
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer (Revenue) Market Share in 2022
Figure Top 10 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
Table Key Manufacturers HIV Integrase Strand Transfer Inhibitors (INSTI) Product Type
Table Mergers & Acquisitions Planning
Table Adcock Ingram Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Adcock Ingram Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Adcock Ingram Limited 2018-2023
Table Adcock Ingram Limited Main Business
Table Adcock Ingram Limited Recent Development
Table Flamingo Pharmaceuticals Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Flamingo Pharmaceuticals Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Flamingo Pharmaceuticals Limited 2018-2023
Table Flamingo Pharmaceuticals Limited Main Business
Table Flamingo Pharmaceuticals Limited Recent Development
Table Biocon Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Biocon Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biocon Limited 2018-2023
Table Biocon Limited Main Business
Table Biocon Limited Recent Development
Table Affine Formulations Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Affine Formulations Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Affine Formulations Limited 2018-2023
Table Affine Formulations Limited Main Business
Table Affine Formulations Limited Recent Development
Table Emcure Pharmaceuticals Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Emcure Pharmaceuticals
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Emcure Pharmaceuticals 2018-2023
Table Emcure Pharmaceuticals Main Business
Table Emcure Pharmaceuticals Recent Development
Table Aurobindo Pharma Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Aurobindo Pharma
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aurobindo Pharma 2018-2023
Table Aurobindo Pharma Main Business
Table Aurobindo Pharma Recent Development
Table Hetero Drugs Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Hetero Drugs
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hetero Drugs 2018-2023
Table Hetero Drugs Main Business
Table Hetero Drugs Recent Development
Table Cipla Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Cipla
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cipla 2018-2023
Table Cipla Main Business
Table Cipla Recent Development
Table Bristol-Myers Squibb Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Bristol-Myers Squibb
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2018-2023
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Gilead Sciences Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Gilead Sciences
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gilead Sciences 2018-2023
Table Gilead Sciences Main Business
Table Gilead Sciences Recent Development
Table Merck Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Merck
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2018-2023
Table Merck Main Business
Table Merck Recent Development
Table Shanghai Desano Pharmaceuticals Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Shanghai Desano Pharmaceuticals
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shanghai Desano Pharmaceuticals 2018-2023
Table Shanghai Desano Pharmaceuticals Main Business
Table Shanghai Desano Pharmaceuticals Recent Development
Table IPCA Laboratories Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of IPCA Laboratories
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of IPCA Laboratories 2018-2023
Table IPCA Laboratories Main Business
Table IPCA Laboratories Recent Development
Table Mylan Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Mylan
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2018-2023
Table Mylan Main Business
Table Mylan Recent Development
Table Medisist Pharma Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Medisist Pharma
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Medisist Pharma 2018-2023
Table Medisist Pharma Main Business
Table Medisist Pharma Recent Development
Table Janssen Pharmaceutica (Johnson & Johnson) Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Janssen Pharmaceutica (Johnson & Johnson)
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Janssen Pharmaceutica (Johnson & Johnson) 2018-2023
Table Janssen Pharmaceutica (Johnson & Johnson) Main Business
Table Janssen Pharmaceutica (Johnson & Johnson) Recent Development
Table ViiV Healthcare (GSK) Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of ViiV Healthcare (GSK)
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ViiV Healthcare (GSK) 2018-2023
Table ViiV Healthcare (GSK) Main Business
Table ViiV Healthcare (GSK) Recent Development
Table Ranbaxy Pharmaceuticals Company Profile
Table HIV Integrase St
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
